Date post: | 14-Dec-2015 |
Category: |
Documents |
Upload: | myles-doncaster |
View: | 216 times |
Download: | 2 times |
SUMMARY AND TAKE HOME MESSAGES
•“Rare” forms of glycosylation are not rare or insignificant
•Technical limitations slowed their identification
•O-linked Mannose-based glycans are abundant in brain•These chains are prominent on -dystroglycan•Altered O-Mannose glycans cause Muscular Dystrophy
•O-Fucose, O-Glucose found in EGF domains•Notch signaling pathways depend on glycosylation
•Other forms of glycosylation are likely to have functions
RARE FORMS OF GLYCOSYLATION
Discovery
Minor component in an abundant source
Thorough analysis of a well known or important molecules
Antibody against a “glycan”
Dedicated analysis of mixtures of glycans, proteins or organs
Chance
RARE FORMS OF GLYCOSYLATION
Roadblocks to Discovery
Degradation and analysis is difficult Minor amounts Biosynthetic route is unknown Tools required are often state of the art level
Significance
Ranges from Unknown-----> critically important Primitive eukaryotic function - selection and
adaptation to specific needs in mammals
Urinary Oligosaccharides and Glycosides
OligosaccharidesXyl1,3Glc 5-10*Fuc1,2Glc 5-10
GlycopeptidesXyl-Ser 1Gal-Hyl 12GlcNAc-Asn 4Glc1,3Fuc-Thr 0.2
*Not reported in proteins
What are the functions of these modifications?
Little effect on half-life or activity of clotting proteins
How about other proteins with EGF modules?
Now it gets interesting
Notch - an EGF Signaling Protein
• Signaling molecule from C. elegans Humans
• Signals induced in binding to Delta or Jagged (serrate) on adjacent cells
• Signaling defects in Notch cause abnormal development, leukemia and a complex disease of Cerebral Artiopathy and Infarcts
• Human Notch-1 (of 4) contains 12 O-Fucose and 17 O-glucose modification consensus sites
• Could these be involved in Signaling????
Are the Sugar Chains Important for Anything?
• Half of the glycosylation sites are conserved across species (3, 4, 10, 12-14, 13, and 14 all contain conserved sites).
• The EGF modules 11 and 12 are essential for binding to Delta. Modules 10, 12, 13, and 14 all contain conserved sites
• Abnormal wing vein mutations occur in modules 24-29.
• Human disorders have been tracked to mutations in Notch 3.
• Fringe proteins differentially modify Notch binding to Delta and Serrate. Wonder what fringe is…....
Are the Sugar Chains Important for Anything?
• Mammalian fringe homologs exist--manic, lunatic, radical
• Fringe must be expressed in the same cell as Notch to exert its effect. Fringe is secreted.
Notch and its ligands both contain EGF domains
Notch
Delta
Serrate
SIGNALSSIGNALS
SIGNALSSIGNALS
SIGNALSSIGNALS
SIGNALS
FRINGE GENES
Jagged Jagged Jagged
Notch Notch Notch + manic+lunatic
Fringe proteins modify Notch/ligand binding and signaling
Lunatic and manic modify different EGF modules
FRINGE IS A GLYCOSYL TRANSFERASE!!!
ARE YOU REALLY SURPRISED?
FucSer/Thr+UDP-GlcNAc GlcNAc,1,3FucSer/Thr
Gal1,4GlcNAc,1,3Fuc
MINIMAL GLYCAN INVOLVED IN NOTCH SIGNALINGThat requires 1,4GalT, the usual one for N-linked chains
DON’T FORGET
Glc,1,3FucThr
FOUND IN HUMAN URINE AND CHO CELLSADDITIONAL FUNCTIONS?
BAH-- ASP/ASN HYDROXYLATION
Mice have developmentalAbnormalities andare also prone tointestinal polyps
Muscular Dystrophies
*MEB-Muscle Eye Brain Disease--POMGnT1(1p32-34)Encodes a 1,2GlcNAc transferase specific for O-Man
Fukuyma-type CMD--fukutin (9q31)Encodes a glycosylt’ase--O-mannosyl transferase(?)
Fukutin Related protein--(19q13.3)dystroglycan misglycosyaltion and laminin deficiency
Overexpression of a specific 1,4GalNAc transferase reversesMD in a model of Duchenne MD (dystrophin)
Common Features:Affects -dystroglycan glycosylation and not -dystroglycan
Heriditary Inclusion Body Myopathy II (9p12-13)UDP-GlcNAc epimerase/kinase used for CMP-Sia
Muscular Dystrophies
MEB-Muscle Eye Brain Disease--POMGnT1(1p32-34)Encodes a 1,2GlcNAc transferase specific for O-Man
Fukuyma-type CMD--fukutin (9q31)Encodes a glycosylt’ase--O-mannosyl transferase(?)
*Fukutin Related protein--(19q13.3)dystroglycan misglycosyaltion and laminin deficiency
Overexpression of a specific 1,4GalNAc transferase reversesMD in a model of Duchenne MD (dystrophin)
Common Features:Affects -dystroglycan glycosylation and not -dystroglycan
Heriditary Inclusion Body Myopathy II (9p12-13)UDP-GlcNAc epimerase/kinase used for CMP-Sia
Muscular Dystrophies
MEB-Muscle Eye Brain Disease--POMGnT1(1p32-34)Encodes a 1,2GlcNAc transferase specific for O-Man
Fukuyma-type CMD--fukutin (9q31)Encodes a glycosylt’ase--O-mannosyl transferase(?)
Fukutin Related protein--(19q13.3)dystroglycan misglycosyaltion and laminin deficiency
*Overexpression of a specific 1,4GalNAc transferase reversesMD in a model of Duchenne MD (dystrophin)
Common Features:Affects -dystroglycan glycosylation and not -dystroglycan
Heriditary Inclusion Body Myopathy II (9p12-13)UDP-GlcNAc epimerase/kinase used for CMP-Sia
C-Mannosylation - Novel C-C bond
Consensus sequence in 100’s of proteins and wide-spread in mammalian cells. Mannosyl transferase present in many cells.
Antibody and structural determination are keys to finding this unusual form of protein modification
WXXW--
Thrombospondin has Man(C)--TrpAnd Glc-Fuc-O-disaccharide in EGF domains
Man(C)--Trp Glc-Fuc--O-Ser/Thr
368 377420 432423 ---480 489
Residues implicated in binding to GAG chains
GLYCOSYLATION + AMINO ACID MODIFICATION
A RECURRING THEME IN RECOGNITION?
Sugar chain
Tyr-SO4
P-Selectin C-Type Lectin
Domain
CR-Repeat
EGF-Domain
Q - A - T - E - Y - E - Y - L - D - Y - D - F - L - P - E - T - E - P - P - 42 46 48 51 57
3
16
4
3
3
3
O
SO3
-O
SO3
-O
SO3
-